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Primary CD4 T lymphocyteHIV-1 infection in cell lines is very efﬁcient, since the target population is clonal and highly dividing.
However, infection of primary cells such as CD4 T lymphocytes and monocyte-derived macrophages is much
more difﬁcult, resulting in a very small percentage of infected cells. In order to study events occurring in
productively infected primary cells, we determined that a way to isolate this population from bystander cells
was needed. We engineered a novel HIV-1-based reporter virus called NL4-3-IRES-HSA that allows for the
magnetic separation of cells infected with fully competent virions. This X4-using virus encodes for the heat-
stable antigen (HSA/murine CD24) without the deletion of any viral genes by introducing an IRES sequence
between HSA and the auxiliary gene Nef. Using commercial magnetic beads, we achieved efﬁcient
puriﬁcation of HIV-1-infected cells (i.e. purity N85% and recovery N90%) from diverse primary cell types at
early time points following infection. We used this system to accurately quantify p53 protein levels in both
virus-infected and uninfected bystander primary CD4+ T cells. We show that p53 up-regulation occurs
exclusively in the infected population. We devised a strategy that allows for an efﬁcient separation of HIV-1
infected cells from bystanders. We believe that this new reporter virus systemwill be of great help to study in
depth how HIV-1 interacts with its host in a primary cells context.
© 2009 Elsevier Inc. All rights reserved.Introduction
A previous microarray study involving HIV-1 and primary CD4+ T
cells pointed out the need to isolate HIV-1-infected cells from the total
population for further analysis (Imbeault et al., 2009). Indeed, in vitro
infection rates in human primary cells are very low, reaching about 1%
in PHA-activated CD4+ T lymphocytes after 24 h of infection. This
percentage can reach an average of 10% at 4 days post-infection. This
situation is in sharp contrast to the very high infection rates routinely
seen in the majority of CD4-expressing established cell lines (e.g.
Jurkat). Such low infection rates make it hard to detect potential
changes in gene and/or protein expression occurring exclusively in
infected cells, the signal being diluted in the total cell population.
Moreover, it complicates the discrimination between processes that
occur exclusively in infected cells from those taking place in
uninfected bystander cells using techniques such as Western blot or
quantitative real-time PCR (qRT-PCR).virologie Humaine, Centre de
ier, Québec (QC), Canada G1V
M.J. Tremblay).
l rights reserved.Reporter viruses are essential tools to follow the HIV-1 life cycle by
making it possible to easily identify productively infected cells and
quantify the total level of virus infection. Engineered from the basic
HIV-1 genome, the encoded reporter protein can be measured or
detected by biochemical means or ﬂow cytometry. Examples of the
most commonly used reporter genes include enhanced green
ﬂuorescence protein (eGFP) (Brown et al., 2005; Herbein et al.,
1998; Kutsch et al., 2002; Rich et al., 2002), luciferase (Connor et al.,
1995) and membrane-bound proteins that can be targeted by
ﬂuorescent-labelled antibodies such as murine heat-stable antigen
(HSA) (Chiu et al., 2005; Jamieson and Zack, 1998; Marodon et al.,
1999) and human placental alkaline phosphatase (PLAP) (Chen et al.,
1996; He and Landau, 1995). Some techniques even allow tracking of
HIV-1 particles by tagging virus-encoded proteins that are incorpo-
rated into mature virions such as Gag (Muller et al., 2004) and Vpr
(McDonald et al., 2002). However, given the complexity and compact
size of the HIV-1 genome, insertion of reporter genes in different loci
(such as Nef, Vpu, Vpr or Gag) often disrupts the expression or activity
of viral proteins. In human primary cells, the introducedmodiﬁcations
can severely cripple viral replication, especially in non-dividing cells
(reviewed in Li et al. (2005)). Moreover, results obtained with these
viruses can sometimes lead to conclusions not relevant in a full-length
virus context as every viral protein has a deﬁnite role to play in the
virus replicative cycle.
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construct into which the reporter gene eGFP was inserted in front of
an IRES sequence and the Nef gene, thus avoiding deletion or
inactivation of a so-called accessory gene. Previous observations
indicate that this strategy allows expression of Nef protein at levels
comparable to what is seen in wild-type virus (Brown et al., 2005).
Such eGFP-expressing reporter virus could in theory be used to isolate
productively infected cells from the total cell population using a ﬂow
cytometry cell sorter apparatus. However, there are some technical
problems associated with this approach. For example, a high speed
cell sorter in a biosafety level 3 facility is required — getting the
infected cells out of this protected environment requires virus
inactivation through ﬁxation with paraformaldehyde or other agents
(e.g. methanol or ethanol), which have a negative impact on eGFP
ﬂuorescence (Kusser and Randall, 2003), membrane permeability
(which causes cytosolic eGFP to leak out) (Kalejta et al., 1997) and/or
integrity of both RNA and proteins (for crosslinking agents).Fig. 1. Cloning strategy used to generate the NL4-3-IRES-HSA vecWe postulated that a virus encoding for a membrane reporter
protein along with all viral genes was needed in order to study HIV-1-
induced gene expression in human primary HIV-1-infected and
uninfected bystander cells. We therefore constructed a novel HIV-1-
based reporter virus by replacing eGFP with HSA in the NLENG1-IRES
vector. Such a viral construct expresses all viral proteins and can serve
to separate infected cells using commercially availablemagnetic beads
coated with an antibody speciﬁc for the membrane-bound HSAwhich
is expressed along early virus genes upon productive infection. We
named the new construct NL4-3-IRES-HSA and derived also R5-tropic
(NL4-3-Bal-IRES-HSA) and Env-deﬁcient variants.
In order to demonstrate the usefulness of NL4-3-IRES-HSA, we
separated HIV-1-infected primary CD4+ T cells from bystander cells
following infection and quantiﬁed p53 protein expression levels. p53
phosphorylation and subsequent accumulation are a hallmark of HIV-
1-induced apoptosis (Castedo et al., 2005). However, there is still no
information as to whether HIV-1 is able to induce p53-dependenttor. See Materials and methods section for complete details.
Fig. 2. Infection kinetics of reporter constructs in human primary CD4+ T cells. (A)
Target cells were infected with a similar number of infectious NL4-3-IRES-HSA and
NLENG1-IRES viruses before quantifying the percentage of HSA- and eGFP-positive
cells, respectively, at the indicated time points. The difference between HSA and eGFP
signals for a same level of infection has been observed in multiple experiments. (B) At
3 days post-infection, cells were triple stained with anti-HSA (red), intracellular anti-
p24 (green) and DNA dye DRAQ5 (blue). The central slice of a confocal microscopy stack
is represented.
162 M. Imbeault et al. / Virology 393 (2009) 160–167apoptosis in bystander cells, infected cells or both. In this manuscript
we demonstrate that p53 up-regulation happens exclusively in the
cell population productively infected with HIV-1, thus supporting the
hypothesis that DNA damage induced by HIV-1 integration is required
for p53 accumulation.
Results
Construction and in vitro replication of NL4-3-IRES-HSA
In order to generate a reporter virus that would express all viral
genes along with a membrane-bound protein suitable for magnetic
bead-based separation, we replaced eGFP for HSA in NLENG1-IRES.
HSA is an ideal candidate for a reporter gene because of its very
small size (about 200 nucleotides) which is important in a compact
viral genome context as to minimize interference with viral replica-
tion kinetics. Natural selection over multiple infection cycles would
tend to eliminate a large insert to optimize the virus replicative ﬁtness.
We devised a PCR-based cloning technique which can easily be
adapted to insert any reporter gene in the HIV-1 genome, provided
that it does not contain BamHI or XhoI restriction enzyme recognition
site (Fig. 1). In addition, we constructed R5-tropic (Bal) and Env-
deﬁcient variants of NL4-3-IRES-HSA.
We ﬁrst made comparative analyses of NLENG1-IRES and NL4-3-
IRES-HSA in mitogen-stimulated CD4+ T cells. To this end, target cells
were inoculated with similar amounts of reporter viruses that were
standardized in terms of infectious units per ng of p24 through the use
of the TZM-BL reporter cell line. Although virus production as
monitored by measuring the p24 content in cell-free supernatants
was comparable for the two tested reporter viruses (data not shown),
the number of cells productively infected with HIV-1 we could detect
was on average two-fold higher with the new construct compared to
the eGFP-encoding viral vector (Fig. 2A). It can be concluded that HSA
is a more sensitive means of detecting early virus gene expression in a
cell subpopulation considered as a major cellular reservoir for HIV-1,
namely CD4+ T lymphocytes. It should be noted that relatively low
infection levels are not due to the use of lowmultiplicity of infection, as
addingmore virus (up to 10 fold) did not translate into higher infection
levels (data not shown). Laser scanning confocal microscopy of cells
infected with NL4-3-IRES-HSA virus conﬁrmed that HSA is expressed
as an early gene since all cells positive for the major core protein p24
(considered as a late protein) also express HSAwhile the reverse is not
true (Fig. 2B and data not shown). Importantly, replication kinetics
of wild-type NL4-3 and NL4-3-IRES-HSA virions in human primary
CD4+ T cells were found to be similar, thus suggesting that Nef is
still functional in the NL4-3-IRES-HSA construct (data not shown).
NL4-3-IRES-HSA allows for an efﬁcient magnetic bead-based separation
of infected cells
Wenext proceeded to isolate cells expressing earlygene products of
HIV-1. This task was achieved by inoculating human primary CD4+ T
cells and MDMs with fully infectious NL4-3-IRES-HSA or NL4-3-Bal-
IRES-HSA reporter virus, respectively, before separationwith EasySep®
magnetic nanoparticles (Biotin Selection Kit, StemCell Technologies
Inc.). We found that the purity of isolated cells ranged from 80 to
94% and recovery rates of 85 to 90% were obtained routinely with
both cell types (Fig. 3). The technique is able to recover cells at early
time points (24 h) even when few infected cells are present (less
than 0.5%). Sufﬁcient amounts of cells to perform Western blot
analyses and qRT-PCR tests could consistently be harvested, provided
that 5×105 to 1×106 HSA-expressing cells were available in the
starting sample. The purity and recovery rates of the target population
were assessed either by ﬂow cytometry or laser scanning microscopy
(LSM). The latter method is preferred for routine analysis of the
isolated cell population as it can be achieved using much loweramounts of cells (i.e. 5×103) compared toﬂowcytometry (i.e. ~1×105
cells). Nevertheless, we used ﬂow cytometry studies to establish the
initial purity and enrichment rates because it is a useful technique for
quantitative assessment of a speciﬁc cell marker and is less labor-
intensive than LSM. Subsequent characterization at pre and post
immuno-magnetic cell separation by confocal microscopy conﬁrmed
that the isolated populations are highly enriched (Fig. 4).
p53 is stabilized in HIV-1 infected cells but not in bystander cells
In order todemonstrate theutility of the viral reporter construct,we
infected PHA-activatedprimaryCD4+T lymphocyteswithNL4-3-IRES-
HSA for 72 h. We then proceeded to magnetic bead-based separation
using a biotinylated antibody against HSA as described previously.
Whole protein extracts were obtained from the positive (infected) and
negative (bystander) fractions as well as from unseparated cells and
mock-treated cells. Next, we quantiﬁed p53 protein levels from these
extracts by Western blot. The rationale behind this experiment was to
verify whether virus-mediated p53 stabilization is occurring in
infected and/or uninfected CD4+ T cells. Results illustrated in Fig. 5
demonstrate that a signiﬁcant increase in the p53 protein level is seen
at 72 h post-infection only in the CD4+ T cell population that is
expressing HIV-1 early gene products as monitored by HSA staining
and not in uninfected bystander cells. Similar ﬁndings were made
when infection was allowed to proceed for 48 h (data not shown).
Fig. 3. Efﬁciency of magnetic bead-based infected cells separation. (A) Flow cytometry analysis of primary CD4+ T lymphocytes infected with NL4-3-IRES-HSA 2 days post-infection.
(B) Flow cytometry analysis of the same cell population post-separation with magnetic beads. (C) Flow cytometry analysis of monocyte-derived macrophages infected with NL4-3-
Bal-IRES-HSA, 9 days post-infection. (D) Flow cytometry analysis of the same cell population post-separation with magnetic beads (positive fraction).
Fig. 4. Confocal microscopy analysis of primary CD4+ T lymphocytes infected with NL4-3-IRES-HSA. Unseparated infected cells, positive (infected cells) and negative (bystander
cells) fractions following the magnetic separation procedure are shown. A signiﬁcant enrichment of infected cells is achieved in the positive fractionwhile simultaneously depleting
the negative fraction, yielding bystander cells. HSA-positive cells are indicated with a star (⁎). Highly ﬂuorescent aggregates in the positive fraction are magnetic beads coated with
ﬂuorescent-labelled antibodies against HSA.
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Fig. 5. HIV-1 induces p53 expression in virus-infected cells. (A) Human primary CD4+ T
cells were infected for 3 days with NL4-3-IRES-HSA and whole proteins were extracted
frommock-infected, unseparated/infected, separated/HSA-negative (called bystanders)
and separated/HSA-positive cells (called infected). Next, p53 and β-actin protein levels
were estimated by Western blot analysis using speciﬁc antibodies. (B) Percentage of
increase over mock-infected cells has been determined by estimating the signal band
intensities for p53 normalized on β-actin by laser densitometry scanning using ImageJ.
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Reporter viruses are essential tools in the quest for a better
understanding of HIV-1 biology, allowing scientists to efﬁciently track
infection events within a population of cells exposed to the virus. Over
the last few years, many variants of such tools have been developed,
each with its own advantages and drawbacks geared toward a speciﬁc
application.
As the infection efﬁciency of HIV-1 is known to be an order of
magnitude lower in primary human cells compared to immortalized
cell lines, a convenient/efﬁcient/sensitive method to separate virus-
infected cells from the bystander population is needed to study the
infection process in ﬁne detail at early time points. Some available
reporter virus constructs expressing surface molecules such as HSA or
PLAP could have been used for this purpose. However, all existing viral
constructs expressing these membrane-bound proteins lack one or
more viral genes such as Nef, Vpr and/or Env. One important caveat
related with the use of these vectors is that the deleted proteins have
important functions in the in vivo and in vitro replicative capacity and
cytopathogenicity of HIV-1. For example, Nef protein has been shown
to modulate expression of numerous cell surface molecules (e.g. CD4,
CD8, CD28, MHC-I and MHC-II). This auxiliary virus-encoded protein
can also interfere with cellular signal transduction pathways, enhance
virion infectivity and regulate cholesterol trafﬁcking in HIV-1-infected
cells (reviewed in Li et al. (2005)). On the other hand, Vpr mediates
nuclear import of the viral pre-integration complex, promotes a cell
cycle G2 phase arrest, displays pro-apoptotic properties and
diminishes humoral and cellular immune responses through an effect
on cell proliferation or production of cytokines/chemokines (e.g. TNF-
α, IL-12, RANTES, MIP-1α and MIP-1β) (reviewed in Li et al. (2005)).In an attempt to overcome these serious limitations, we built the new
reporter virus NL4-3-IRES-HSA by introducing the small reporter gene
of murine origin HSA followed by an IRES sequence inserted in frame
with the Nef locus in order to maintain the complete viral genome.
Being located near the Nef sequence, HSA is expressed as an early gene
and can be efﬁciently detected as soon as 24 h post-infection in both
CD4+ T cells and MDMs, although the percentage of positive cells at
such an early time point is extremely low (data not shown). The
cloning strategy we devised is very ﬂexible and allows for any other
reporter gene to be cloned in place of HSA, provided that the selected
gene does not contain recognition sites for the BamHI or XhoI
restriction enzymes. Promising candidates for future consideration
include variants of luciferase and the HSA-HA construct developed by
Ali and Yang (2006). Both of these tools would be useful to study viral
ﬁtness in a complete virus backbone.
The higher frequency of HIV-1-infected CD4+ T cells we can detect
when infection is performed with a similar amount of infectious NL4-
3-IRES-HSA compared to the parental NLENG1-IRES can be explained
by a combination of factors. First, eGFP is distributed throughout the
entire cytoplasm while HSA is concentrated in lipid rafts on the
plasma membrane because this cell surface molecule carries a
glycosylphosphatidylinositol anchor. Therefore, a higher concentra-
tion thresholdmust be achieved to detect a signal with eGFP thanwith
HSA. In this regard, intracellular p24 staining suffers from the same
weakness, along with the fact that it is expressed later in the viral life
cycle than HSA in our construct. Moreover, eGFP intensity is negatively
affected at different degrees by ﬁxation with various agents such as
paraformaldehyde, ethanol, and methanol. In addition, eGFP is highly
soluble in the cytoplasm and can leak from cells ﬁxed with
permeabilizing agents such as ethanol. Fixation is often a necessity
to manipulate infected cells outside a level 3 bioconﬁnement area. For
all these reasons, we found that a reporter virus expressing a
membrane-bound molecule such as HSA constitutes a better choice
for microscopy and ﬂow cytometry applications than eGFP-based viral
constructs.
Our separation techniquewas optimized using the EasySep® Biotin
Selectin kit from StemCell Technologies Inc. in combination with a
biotinylated anti-HSA antibody. We routinely achieved a degree of
purity greater than 85% and a recovery rate higher than 80% in both
PHA-activated primary human CD4+ T lymphocytes and MDMs.
Moreover, we have been able to successfully isolate HIV-1-infected
cells from mitogen-activated peripheral blood mononuclear cells and
peripheral blood lymphocytes as well as from human lymphoid
tissues cultured ex vivo (i.e. small blocks of tonsils) (data not shown).
Depending on the cell type and the time frame between initial
infection and analysis, the quantity of primary cells necessary to
obtain a signiﬁcant number of virus-infected cells is a limiting factor.
For instance, to isolate 5×105 HIV-1-infected CD4+ T cells at 24 h
post-infection, the starting material should be equal to a total
population of at least 50×106 cells. Another limitation was seen
when using phagocytic cells as targets. Indeed, the natural tendency of
such cells to engulf magnetic particles results in a non-speciﬁc
separation and thus a diminished purity. This technical problem was
alleviated by performingmagnetic separation at 4 °C, an experimental
condition known to reduce phagocytosis. We found that viability of
infected cells following the separation process was not optimal most
likely due to the high level of viral replication they sustain. Therefore,
the isolated cells should be used immediately after isolation for
techniques that do not require live cells, such as Western blot, qRT-
PCR or microarray studies.
It has been established that HIV-1 can induce apoptosis in CD4+ T
lymphocytes by distinct pathways (Varbanov et al., 2006). However,
there is still controversy about the precise mechanism(s) andwhether
apoptosis is occurring in infected cells (Genini et al., 2001; Petit et al.,
2002), uninfected bystander cells (Castedo et al., 2002), or both. As a
simple demonstration of the utility of our reporter molecular
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CD4+ Tcells after 3 days following acute virus infection and quantiﬁed
the amount of p53, a protein playing a well characterized role in HIV-
1-induced apoptosis (Castedo et al., 2005; Corbeil et al., 2001; Komoto
et al., 2002; Perfettini et al., 2005a, 2005b). It has been shown that p53
is controlled at a post-transcriptional level by HDM2, which binds to
and ubiquitinylates p53, targeting it to the proteasome and preventing
it from translocating to the nucleus to activate pro-apoptotic genes
(Momand et al., 1992). Phosphorylation prevents HDM2 binding and
allows for p53 accumulation. Our data clearly indicate that the virus-
mediated p53 up-regulation is taking place in cells productively
infected with HIV-1. This supports the hypothesis which proposed
that DNA integration events and the subsequent DNA damage are
necessary to lead to the p53-dependent apoptosis seen in the context
of an HIV-1 infection (Genini et al., 2001). Interestingly, our results
demonstrate that apoptosis in bystander CD4+ T lymphocytes does
not appear to be dependent on p53 as no stabilization of the protein is
detected in this cell population. Additional studies conducted in
human primary CD4+ T cells are needed to deﬁne how HIV-1 can
mediate apoptosis in a p53-independent manner in uninfected
bystander cells. It should be noted that a weak 1.77-fold increase in
p53 expression was detected in the total unseparated cell population.
This small increment could have been dismissed if our work was
focusing only on the total cell population. Therefore, infection studies
performed with the presently described HIV-1-based reporter virus
show that it fulﬁlls its original goals that are to allow detection of HIV-
1-dependent biological events occurring in a small number of cells
and to determine whether HIV-1 can initiate metabolic changes in
virus-infected versus uninfected bystander cells. In conclusion, we
provide in this manuscript evidence that the NL4-3-IRES-HSA vector
constitutes a worthy addition to the virologist's toolbox, even if it can
only be used in an in vitro setting. It has the potential for identifying
HIV-1-induced proteomic and genomic changes in a small cell popu-
lation and discriminating events generated in infected and/or unin-
fected cells. This knowledge is essential to obtain a more detailed
understanding of early events in the process of HIV-1 infection and
identify the gene/protein expression signature unique to this retrovirus.
Materials and methods
Construction of NL4-3-IRES-HSA
PCR sewing, also known as “fusion PCR”, was used to derive NL4-
3-IRES-HSA from the original NLENG1-IRES vector (see Fig. 1 for more
detailed information). Brieﬂy, the NLENG1-IRES vector contains a
full-length HIV-1 NL4-3-based genome with eGFP inserted in
between the env and nef genes so that eGFP is expressed as an
early and a late gene, as if it was Nef (kindly supplied by D.N. Levy,
New York University College of Dentistry, New York, NY) (Levy et al.,
2004). Nef expression is achieved by insertion of an IRES between
eGFP and nef, yielding wild-type levels of Nef protein. HSA was
ampliﬁed from a plasmid source with primers containing tails
complementary to NL4-3 and ﬂanking each side of eGFP in
NLENG1-IRES (Table 1). Fragments ﬂanking eGFP were ampliﬁedTable 1
Primers used to build NL4-3-IRES-HSA.
Outer 5′ - GAATTAGATAAATGGGCAAGTTTGTGG
Inner 5′ - GCTGTACTTTCTATAGTGAATAGAGTTA
Reverse 5′ - (CCACCATCGCTCTGCCCAT)CTTATAGCAAAATCCTTTCCAAGCC
HSA-F - (GGCTTGGAAAGGATTTTGCTATAAG)ATGGGCAGAGCGATGGTGG
HSA-R - AACCCTCCATGGTGGCGGC(CTAACAGTAGAGATGTAGAAG)
Forward 3′ - (CTTCTACATCTCTACTGTTAG)GCCGCCACCATGGAGGGTT
Inner 3′ - TTGCTACTTGTGATTGCTCCATG
Outer 3′ - GGCACAAGCAGCATTGTTAGCfrom NLENG1-IRES with primers containing tails complementary to
HSA using Phusion polymerase (Finnzymes, Finland). All three
fragments were puriﬁed on gel using Qiagen Gel Extraction kits
and quantiﬁed by spectrophotometry. Equivalent amounts of all three
fragments were mixed in a primerless PCR reaction and allowed to
anneal for 5 cycles of denaturation (94 °C for 30 s), annealing (50 °C
for 30 s) and extension (72 °C for 45 s). Thereafter, inner primers
were added to the mix and the reaction was allowed to proceed for
25 additional cycles. A 1200 basepair amplicon containing the three
fused fragments was isolated on gel and then digested with BamHI
and XhoI restriction enzymes. Puriﬁcation was performed on a
Qiagen column to get rid of small fragments, enzymes and buffer. The
resulting fragment was ligated back in NLENG1-IRES to generate NL4-
3-IRES-HSA or the Env-negative version of the same construct to
generate NL4-3-IRES-HSA ENV–. The SalI–BamHI fragment that
contains most of the env gene from NL4-3Balenv (Dornadula et al.,
1999) was swapped in place of the native NL4-3 env gene in NL4-3-
IRES-HSA, generating a CCR5-tropic, replication competent HSA-
encoding viral construct (called NL4-3-Bal-IRES-HSA).
Cell separation
Virus-infected and uninfected bystander cells were isolated using
the EasySep® Biotin Selection kit as suggested in the manufacturer's
protocol (StemCell Technologies Inc., Vancouver, BC) with slight
modiﬁcations. Five rounds of separation of 7 min each were carried
out. Only the fraction from the ﬁrst round of separation was kept as a
negative fraction. Experiments were performed with 0.5% BSA instead
of 2% FBS. For some applications the protocol was carried out at 4 °C
and incubation times were doubled. Isolation of adherent MDMs was
achieved through the use of Versene (PBS supplemented with 5 mM
EDTA). The biotinylated anti-HSA antibody (clone M1/69, BD
Biosciences) was used at a ﬁnal concentration of 3 μg/ml in all
experiments.
Confocal microscopy
Puriﬁed populations of HIV-1-infected CD4+ T lymphocytes were
seeded on 12 mm poly-L-lysine-coated coverslips (BD Biosciences)
and ﬁxed with 4% paraformaldehyde. Cells were then permeabilized
using 0.1% Triton X-100, and non-speciﬁc bindingwas blockedwith 1%
BSA, 10% goat serum and 10% pooled human serum in PBS. In order to
detect HIV-1-infected cells, the anti-HSA antibody was ﬁrst used
(1:300 dilution), followed by washes in PBS and staining with mouse
anti-rat IgG conjugated to Alexa555. In some cases, cells were also
stained for DNA using DRAQ5 (Biostatus), HIV-1 p24 capsid protein
using FITC-conjugated anti-p24 (clone KC57, Coulter Clone), or F-actin
using Alexa488-conjugated phalloidin (Molecular Probes). Cells were
then mounted with Fluoromount (Southern Biotech, InterScience)
and visualized with an Olympus FluoView FV300 confocal microscope
(Olympus). Digital images were produced using the Adobe Photoshop
software (version 6.0; Adobe Systems).
Cell culture
Peripheral blood was obtained from normal healthy donors and
peripheral blood mononuclear cells (PBMCs) were prepared by
centrifugation on a Ficoll–Hypaque density gradient. Next, a cell
population highly enriched in CD4+ T lymphocytes was isolated
through the use of the human CD4+ T cell negative selection kit
according to the manufacturer's instructions (StemCell Technologies
Inc.). The purity of the negatively selected cell population was
estimated by quantifying the percentage of CD4-expressing cells.
Next, cells were cultured at a concentration of 2×106/ml in
complete RPMI-1640 medium (Invitrogen, Burlington, ON) supple-
mented with 10% foetal bovine serum (FBS) (Wisent, St-Bruno, QC),
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ml), phytohemagglutinin-L (1 μg/ml) and recombinant human IL-2
(30 U/ml) for 3 days at 37 °C under a 5% CO2 atmosphere prior to
virus infection. Human embryonic kidney 293T cells were main-
tained in Dulbecco's modiﬁed Eagle medium (Invitrogen) supple-
mented with 10% FBS, glutamine (2 mM), penicillin G (100 U/ml)
and streptomycin (100 µg/ml). MDMs were produced by incubating
PBMCs at a concentration of 1.25×106 cells in a T-75 ﬂask for 2 h at
37 °C, thus allowing adherence of monocytes to the bottom of the
ﬂask. Non-adherent cells were then removed and monocytes were
washed twice with RPMI-1640 containing 5% autologous heat-
inactivated plasma and cultured for 1 week in medium supple-
mented with 100 ng/ml macrophage-colony stimulating factor (M-
CSF) to allow differentiation into MDMs.
Preparation of virus stocks
Virus particles were produced by calcium phosphate transfection
in 293T cells using a commercial calcium phosphate coprecipitation
kit according to the manufacturer's instructions (CalPhos Mamma-
lian Transfection Kit, Clontech Laboratories Inc., Palo Alto, CA). In
brief, parental 293T cells were transiently transfected either with
NLENG1-IRES, NL4-3-IRES-HSA, or NL4-3-Bal-IRES-HSA. Cell-free
supernatants from such transfected 293T cells were ﬁltered through
a 0.22-μM-pore-size cellulose acetate membrane (Millipore, Bedford,
MA). To eliminate free p24, each supernatant was ultraﬁltrated in
Centricon® Plus-20 Biomax-100 ﬁlter devices (Millipore Corpora-
tion). Finally, samples were aliquoted before storage at −85 °C.
Stocks of NLENG1-IRES and NL4-3-IRES-HSA reporter virus were
normalized according to p24 and TCID50. Infectivity titration was
determined through the use of the TZM-BL reporter cell line (Wei et
al., 2002) (obtained through the NIH AIDS Repository Reagent
Program; TZM-bl from Dr. John C. Kappes, Dr. Xiaoyun Wu and
Tranzyme, Inc.). All virus preparations underwent only one freeze–
thaw cycle before initiation of infection studies.
Flow cytometry
Flow cytometry analyses were performed with 5×105 cells that
were incubated with 100 μl of PBS (pH 7.4) containing a saturating
amount of a monoclonal anti-HSA antibody for 30 min on ice.
Beforehand, cells were treated with a pool of human serum for 30 min
on ice and then washed with cold PBS, in order to block Fc receptors.
MDMs were maintained in PBS with EDTA (1 mM) throughout the
entire procedure to prevent cells from sticking to the surface of tubes.
Following washes, cells were then labelled for 30 min on ice with
100 μl of a saturating amount of FITC-conjugated goat anti-rat
immunoglobulin G (Caltag). Finally, cells were washed, ﬁxed in 2%
paraformaldehyde for 30 min and analyzed on a cytoﬂuorometer
(EPICS XL, Coulter Corp., Miami, FL).
Western blots
A cell population highly enriched in CD4+ T lymphocytes was
exposed to NL4-3-IRES-HSA for 72 h at 37 °C. Thereafter, proteins were
extracted fromboth virus-infected and uninfected bystander cells. Cell
extracts were heated at 100 °C for 7 min in 1× sample buffer (62 mM
Tris–HCl [pH 6.8], 2% SDS, 5% beta-mercaptoethanol, 9% glycerol and
0.002% bromophenol blue) containing PMSF (1 mM). The samples
were then separated on a 7.5–20% gradient SDS-polyacrylamide gel
and transferred to Immobilon polyvinylidene diﬂuoride membranes
(Millipore, Bedford, MA). Immunoblotting was performed using
antibodies speciﬁc for p53 (clone DO-1, Santa Cruz) or β-actin.
Membranes were labelled with horseradish peroxidase-conjugated
secondary anti-rabbit and anti-mouse antibodies (Jackson ImmunoR-
esearch, Mississauga, ON) at 1:20,000 and 1:10,000 dilutions,respectively. Signals were revealed using the ECL™ Western blotting
detection reagent (Amersham, Piscataway, NJ).
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